Ruyuan Guo

机构：Shanxi Medical University, Shanxi Provincial Cancer Hospital · ORCID：0000-0002-2610-8402

发表论文 18 篇 · 总被引 68 次 · h-index 4

代表论文

• Prognostic Nutritional Index, Another Prognostic Factor for Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (2020 · Frontiers in Oncology · 被引 20)
• First-Line Chemoradiation With or Without Chidamide (Tucidinostat) in Patients With Intermediate- and High-Risk Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma: A Randomized Phase 2 Study in China (2022 · International Journal of Radiation Oncology*Biology*Physics · 被引 15)
• Hemoglobin level, a prognostic factor for nasal extranodal natural killer/T-cell lymphoma patients from stage I to IV: A validated prognostic nomogram (2017 · Scientific Reports · 被引 13)
• A comparison of treatment modalities for nasal extranodal natural killer/T-cell lymphoma in early stages: The efficacy of CHOP regimen based concurrent chemoradiotherapy (2016 · Oncotarget · 被引 7)
• MicroRNA-137 Inhibits Esophageal Squamous Cell Carcinoma by DownregulatingDAAM1 (2022 · Protein and Peptide Letters · 被引 4)
• Development and validation of a model to predict the risk of recurrence in patients with laryngeal squamous cell carcinoma after total laryngectomy (2022 · Annals of Translational Medicine · 被引 3)